About 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol
1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol (PubChem CID 139429379) has the molecular formula C30H30Cl2N6O2
and a molecular weight of 577.52 g/mol. Its IUPAC name is 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol.
Molecular Properties
| Compound Name | 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol |
| PubChem CID | 139429379 |
| Molecular Formula | C30H30Cl2N6O2 |
| Molecular Weight | 577.52 g/mol |
| Exact Mass | 576.18 |
| IUPAC Name | 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol |
| SMILES | Cc1nc(-c2cccc(-c3cccc(-c4cnc(CN5CC(O)C5)c(C)n4)c3Cl)c2Cl)cnc1CN1CC(O)C1 |
| InChI | InChI=1S/C30H30Cl2N6O2/c1-17-27(15-37-11-19(39)12-37)33-9-25(35-17)23-7-3-5-21(29(23)31)22-6-4-8-24(30(22)32)26-10-34-28(18(2)36-26)16-38-13-20(40)14-38/h3-10,19-20,39-40H,11-16H2,1-2H3 |
| InChIKey | SYDQYZJDTWNMQR-UHFFFAOYSA-N |
| XLogP | 4.54 |
| TPSA | 98.50 Ų |
| H-Bond Donors | 2 |
| H-Bond Acceptors | 8 |
| Rotatable Bonds | 7 |
| Heavy Atoms | 40 |
| Complexity | — |
Lipinski Rule of Five
1 violation
| Rule | Value |
| MW ≤ 500 | 577.52 |
| LogP ≤ 5 | 4.54 |
| H-Bond Donors ≤ 5 | 2 |
| H-Bond Acceptors ≤ 10 | 8 |
Analyze 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol with MolForge
Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.
Launch Full Analysis
Frequently Asked Questions
What is the IUPAC name of 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol?
The IUPAC name of 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol (CID 139429379) is 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol.
What is the SMILES notation for 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol?
The canonical SMILES for 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol is Cc1nc(-c2cccc(-c3cccc(-c4cnc(CN5CC(O)C5)c(C)n4)c3Cl)c2Cl)cnc1CN1CC(O)C1.
What is the InChIKey of 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol?
The InChIKey is SYDQYZJDTWNMQR-UHFFFAOYSA-N. The full InChI is InChI=1S/C30H30Cl2N6O2/c1-17-27(15-37-11-19(39)12-37)33-9-25(35-17)23-7-3-5-21(29(23)31)22-6-4-8-24(30(22)32)26-10-34-28(18(2)36-26)16-38-13-20(40)14-38/h3-10,19-20,39-40H,11-16H2,1-2H3.
What are the key properties of 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol?
1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol has a molecular weight of 577.52 g/mol, XLogP of 4.54, 7 rotatable bonds, 2 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for 1-[[5-[2-chloro-3-[2-chloro-3-[5-[(3-hydroxyazetidin-1-yl)methyl]-6-methylpyrazin-2-yl]phenyl]phenyl]-3-methylpyrazin-2-yl]methyl]azetidin-3-ol is sourced from PubChem (CID 139429379), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).